31800-full
Jimum1
Sex: M
Data Quality: 1 star
MS: 35 yrs
Type: Secondary Progressive
Sensation: Moderate
Overall: Moderate
Cognition: moderate
Vision: moderate
Speech: moderate
Swallowing: moderate
Upper limb: moderate
Walking: severe
Jimum1
Male, 65 years
Omaha, NE
Primary Condition
MS and 2 more ▼
Type
Secondary Progressive
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

Jimum1's Dalfampridine (4-AP extended release) is for:

  • MS

Jimum1 has not reported any side effects for Dalfampridine (4-AP extended release).

Jimum1's Dalfampridine (4-AP extended release) History (Stopped)
1 mg Daily Jan 01, 2004 - Jan 01, 2005
Stopped Did not seem to work Jan 01, 2005
Evaluations

About Dalfampridine (4-AP extended release) (Prescription Drug)

Dalfampridine, is an extended release formulation of 4-aminopyridine or 4-AP. It is a potassium channel blocker that is indicated as a treatment to improve walking in patients with multiple sclerosis (MS). Dalfampridine was previously called Fampridine-SR during clinical trials.

Learn more about Dalfampridine (4-AP extended release) in our Dalfampridine (4-AP extended release) Community Report.

Back to Jimum1's Profile